Form 4 for WST West Pharmaceutical Services
Accepted 2025-02-20 00:00:00 ET · period of report 2025-02-18 · accession 0001127602-25-006115 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-20 | 2025-02-18 | WST | Green Eric Mark | Pres, CEO, Board COB, Dir | M - OptEx | $211.00 | +2,461 | 170.4K | +1% | +$519.3K |
| D | 2025-02-20 | 2025-02-18 | WST | Green Eric Mark | Pres, CEO, Board COB, Dir | F - Tax | $211.00 | -700.30 | 169.7K | -0.4% | -$147.8K |
| DM | 2025-02-20 | 2025-02-18 | WST | Green Eric Mark | Pres, CEO, Board COB, Dir | A - Grant | $0.00 | +17.4K | 12.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-18 | M | A | 2,460.99 | $211.00 | 170,369.12 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-18 | F | D | 700.30 | $211.00 | 169,668.82 | D | — | — | |
| 3 | Derivative | Rst. Stock Unit | 2025-02-18 | A | A | 5,256 | $0.00 | 5,256 | D | $0.00 · — to — | 5,256 Common Stock | (F1) This award vests in four equal installments beginning on February 18, 2026. |
| 4 | Derivative | Stock Option (Right to Buy) | 2025-02-18 | A | A | 12,149 | $0.00 | 12,149 | D | $211.00 · 2026-02-18 to 2035-02-18 | 12,149 Common Stock | (F1) This award vests in four equal installments beginning on February 18, 2026. |